Context Therapeutics Inc.CNTXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$-29.31M
↓ 127% below average
Average (5y)
$-12.89M
Historical baseline
Range
High:$-1.03M
Low:$-29.31M
CAGR
+59.5%
Consistent expansion
PeriodValueChange
2024$-29.31M-39.3%
2023$-21.05M-49.4%
2022$-14.09M-55.7%
2021$-9.05M-774.7%
2020$-1.03M+63.5%
2019$-2.84M-